Skip to main content

Find Clinical Trials

Home
Conditions
Muscle Spasticity

Clinical trial condition

Muscle Spasticity

Explore clinical trials studying Muscle Spasticity. Study availability and eligibility vary by location and protocol.

84 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Muscle Spasticity trial results

Completed

Physiologic Studies of Spasticity

NCT00014976

Conditions: Healthy, Motor Neuron Disease, Muscle Hypertonia, +13 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients

NCT01968902

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +12 more
Locations: Multiple Sclerosis Center of Northeastern New York Latham, New York, United States

View Trial Details

Completed

BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity

NCT01575054

Conditions: Muscle Hypertonia, Muscle Spasticity, Muscular Diseases, +6 more
Locations: Downey, California, United States

Daytona Beach, Florida, United States

Montreal, Quebec, Canada

Prague, Czechia

View Trial Details

Completed

Botulinum Toxin (BOTOX) for Cerebral Palsy

NCT00060957

Conditions: Brain Damage, Chronic, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Children's Hospital and Regional Medical Center Seattle, Washington, United States

View Trial Details

Completed

Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Young Children With Cerebral Palsy

NCT02719483

Conditions: Brain Damage, Chronic, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

NCT00047580

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +23 more
Locations: Radiant Research Tucson, Arizona, United States

The Neurology Center Encinitas, California, United States

Northridge Neurological Center Northridge, California, United States

The Neurology Center Oceanside, California, United States

View all 16 locations

View Trial Details

Completed

Assessment and Management of Post-Stroke Spasticity With Botulinum Toxin-A

NCT01751373

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +12 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Completed

Early Use of Botulinum Toxin in Spasticity Post Stroke.

NCT01882556

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +14 more
Locations: Sandwell and West Birmingham NHS Trust Birmingham, West Midlands, United Kingdom

View Trial Details

Completed

Developing Optimal Focal Muscle Vibration for Improving Spasticity

NCT01915342

Conditions: Electrophysiology, Muscle Hypertonia, Muscle Spasticity, +8 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

MDs on Botox Utility (MOBILITY)

NCT00535938

Conditions: Blepharospasm, Cranial Nerve Diseases, Dyskinesias, +15 more
Locations: Toronto, Ontario, Canada

View Trial Details